New insights into the genetics of primary varicosis
Andreas Fiebig, Kiel, Germany
Saturday, December 09, 2017 | 09.00-10.20 | VEN 1 | LECTURE HALL B
Andreas Fiebig obtained his PhD in Biochemistry and Biotechnology at the University of Münster/Germany (see publication in the Journal of Biochemistry in 2005). From 2005 onwards, he was privileged to get involved in the field of high throughput genetics at the Institute of Molecular Genetics in Kiel/Germany. He was the first to establish the genetic background of Chronic Venous Diseases (Heritability of chronic venous disease, Hum Genetic, 2009). In 2017, as part of a large German research group, he identified the first three risk loci for CVD in a GWAS attempt (Sci. Rep. 2017 Apr 4;7:45652).
As managing director of the competence network of chronic venous diseases (Kiel, Berlin), he is involved in various scientific and technical research projects since 2009. Andreas Fiebig also participates in international cooperation projects being project manager as well as speaker of the initiative of competence networks in Life Sciences.
From 2015 to 2017 he was director of the Initiative of competence networks in Life Sciences (Kiel, Berlin, Frankfurt) interacting with international research centers. Since 2017 he is senior director of the Initiative of competence networks in Life Sciences. As managing director of the corresponding operative platform (InterMedCon, since 2016) he will continue the international cooperation with Japan and the Netherlands including INTERREG-Programme MIND (“Medical Innovation Germany Netherland”, Münster, EU).
Specific research interests include (1) mechanisms regulating chronic venous diseases, (2) role of neoangiogenesis, (3) genomic and transcriptomic discovery in human chronic venous diseases disease, and (4) biomarker identification (including genetic) for risk prediction. Technical interests are full automated storage systems, new GWAS approaches, humanoid robotics, tracker technology for cardiovascular diseases and care management concepts.